Does ERBITUX Cause Malignant neoplasm progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Malignant neoplasm progression have been filed in association with ERBITUX. This represents 3.0% of all adverse event reports for ERBITUX.
20
Reports of Malignant neoplasm progression with ERBITUX
3.0%
of all ERBITUX reports
10
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ERBITUX?
Of the 20 reports, 10 (50.0%) resulted in death, 4 (20.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERBITUX. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does ERBITUX Cause?
Rash (114)
Infusion related reaction (44)
Malaise (37)
Speech disorder (32)
Dry skin (31)
Diarrhoea (25)
Pruritus (24)
Death (23)
Adverse event (21)
Dyspnoea (19)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ERBITUX Alternatives Have Lower Malignant neoplasm progression Risk?
ERBITUX vs ERDAFITINIB
ERBITUX vs ERENUMAB
ERBITUX vs ERENUMAB-AOOE
ERBITUX vs ERENUMAB\ERENUMAB-AOOE
ERBITUX vs ERGOCALCIFEROL